Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 3/20 | 0.76 |
| ▸ | NPY2R | P49146 | 3/20 | 0.76 |
| ▸ | NPY4R | P50391 | 3/20 | 0.76 |
| ▸ | NPBWR1 | P48145 | 8/20 | 0.68 |
| ▸ | GHSR | Q92847 | 1/20 | 0.64 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29707863 | 1.00 | NPY1R (0.76) | NPY1RNPY2RNPY4RNPBWR1GHSR | |
| SCHEMBL29527343 | 0.93 | NPY1R (0.70) | NPY1RNPY2RNPY4RNPBWR1GHSR | |
| SCHEMBL29500559 | 0.90 | CCKBR (0.67) | NPY1RNPY2RNPY4RNPBWR1GHSR | |
| SCHEMBL31105561 | 0.89 | GHSR (0.66) | NPY1RNPY2RNPY4RNPBWR1GHSR | |
| Ser-100 SCHEMBL27712482 | 0.88 | IL23R (0.65) | NPBWR1GHSRKISS1R | |
| SCHEMBL13097862 | 0.88 | IL23R (0.65) | NPBWR1GHSRKISS1R | |
| SCHEMBL14922491 | 0.88 | GHSR (0.77) | GHSR | |
| SCHEMBL29351915 | 0.88 | KISS1R (0.64) | NPY1RNPY2RNPY4RGHSRKISS1R | |
| SCHEMBL28882942 | 0.87 | NPY1R (0.71) | NPY1RNPY2RNPY4RNPBWR1KISS1R | |
| SCHEMBL7027318 | 0.86 | GHSR (0.68) | NPY1RNPY2RNPY4RGHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240002440-A1 | AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS | JPMORGAN CHASE BANK, N.A. | 2024-01-04 | — | — | US | disclosed |